Navigation Links
deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
Date:2/10/2008

New risk variants published today will also be folded into deCODEme(TM)

REYKJAVIK, Iceland, Feb. 10 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODE PrCa(TM), a reference laboratory test for common, single-letter variations in the human genome (SNPs) that the company has associated with increased risk of prostate cancer. deCODE believes the test will be useful for better predicting risk of prostate cancer, helping to optimize both screening and treatment. deCODE PrCa(TM) detects a total of six previously discovered SNPs that have been confirmed in many populations, as well as two SNPs on chromosomes X and 2 that are reported by deCODE scientists in a paper published today in the online edition of Nature Genetics. Although most of the variants individually confer moderate risk, they are common and some are linked to more than less aggressive disease. Consequently, a substantial proportion of men have many risk variants that together confer clinically significant risk. Because of these variants, 10% of men are at twice the risk and 1% of men are at three times the risk of the disease in the general population.

"Through deCODE PrCa(TM), we are bringing together in one tool all of the major genetic risk factors for prostate cancer that we have discovered over the past eighteen months. We believe that this is a test with significant clinical utility for improving and personalizing the screening and treatment of one of the most common cancers. At the same time, we will integrate today's discovery into the prostate cancer module in our personal genome analysis service deCODEme(TM), enabling our subscribers to stay abreast of how the latest discoveries in human genetics may relate to their
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
2. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
5. Hospital Launches Landmark Emergency Medicine Project
6. Watson Launches Generic Biaxin(R) XL
7. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
8. APIC Launches Targeting Zero Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
9. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
10. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
11. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)...  Amgen (NASDAQ: AMGN ) today announced ... president of Gladstone Institutes and Gladstone,s Robert W. and ... are pleased to welcome Dr. Sandy Williams ... , chairman and chief executive officer of Amgen. "Dr. ... his direct experience in our industry will both be ...
(Date:10/17/2014)... 17, 2014 Research and Markets ... and Development Prospect of China Dialysis Market, 2014-2018" ... Based on the 2013 version, this update Report ... dialysis industry and the relevant effect in recent ... industry segmentations. Moreover, it analyzes Chinese private-owned hemodialysis ...
(Date:10/17/2014)... 17, 2014 A victim of medical negligence at ... doctor with a history of alcohol abuse, a physician and ... Prop 46 today, highlighting how Prop 46 will identify and ... The ad pictures a doctor drinking at ... ER."  Proposition 46 will enact the first law in the ...
Breaking Medicine Technology:Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4
... Research Group (MRG), the global authority on medical technology ... a highly competitive and dynamic market, with a small ... this extremely profitable area. As of 2010, the drug-eluting ... most lucrative of the interventional cardiology device markets.   ...
... 5 Osseon Therapeutics, Inc. announced its new ... American Spine Society,s (NASS) annual meeting in Orlando, ... treatment of vertebral compression fractures (VCFs) that may ... metastases.  The Osseoflex DR Steerable Bone Drill features ...
Cached Medicine Technology:Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market 2Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market 3Osseon® Therapeutics Introduces New Osseoflex® DR Steerable Bone Drill 2
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
(Date:10/20/2014)... 2014 Myoderm announced ... Director of their CentralSource service. Matthew ... innovative turnkey drug sourcing, distribution, and management service ... 12 years of industry experience, in both business ... peak of their international success to help clients ...
(Date:10/20/2014)... Viejo, California (PRWEB) October 20, 2014 Final ... announced the release of the Citrus theme for FCPX ... I would use to describe the Citrus theme” Says Christina ... so easy to look so professional.” , Citrus comes with ... Included with the template are: four transitions for added style, ...
(Date:10/20/2014)... 20, 2014 Do you ever feel ... comes a wonderful app Metassessor for teachers, specialists and ... helped its client “Intervention Development LLC” to launch ... is designed for iOS 4.3 or later and is ... is optimized for iPhone 5. It is now available ...
(Date:10/19/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... therapeutic development for Partial Seizure, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Partial Seizure and special features on late-stage ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
... announced that it has launched the authorized generic version of ... ,The company has also launched the authorized generic ... 20 mg, 40 mg and 80 mg yesterday, a company ... entered into separate agreements with Merck that enabled it to ...
... women-only Fatima Jinnah University in Rawalpindi is embroiled in ... ,Opposition members in the National Assembly protested ... sister of Mohammad Ali Jinnah, the founder of Pakistan. ... Daily Times that a portion of the campus had ...
... Sciences (AIIMS) is contemplating leaving the institution, saying he has ... ,"The day I became the dean of AIIMS, ... University in Lucknow. I declined the offer then but might ... R.C. Deka, a leading ENT surgeon in the country and ...
... the numbers of heart transplants are on the decline. This ... properly//. Hence the doctors at the Papworth Hospital in Cambridge ... for five hours after it was removed from the donor. ... transplant was Michael Burt, 58, a builder from Burnham Market, ...
... that researchers will be able to re-establish growth ... by deafness//. ,These tiny hairs in the ear are capable ... into sound. Once lost, these hairs could not be ... one out of every twenty-four people, across the globe, suffered ...
... researchers show that the male survivors of childhood ... recognized and understood// many health care practitioners as ... though both male and female childhood sexual survivors ... about their encounters with health care professionals, there ...
Cached Medicine News:Health News:'Humiliated' Dean Contemplates Leaving AIIMS 2Health News:'Humiliated' Dean Contemplates Leaving AIIMS 3Health News:Latest In the Heart Transplant Field 2Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2
Cytomegalovirus IgM ELISA....
Microforceps: Diamond Dusted Micro Pic Forceps...
Ultra-fine pointed forceps with diamond dusting on inner tip surface for enhanced grasping of tissue. Ideal for fine membrane grasping....
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Medicine Products: